BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15826332)

  • 1. Evidence for controlled heroin use? Low levels of negative health and social outcomes among non-treatment heroin users in Glasgow (Scotland).
    Shewan D; Dalgarno P
    Br J Health Psychol; 2005 Feb; 10(Pt 1):33-48. PubMed ID: 15826332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
    Bloor M; McIntosh J; McKeganey N; Robertson M
    Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent life problems and non-fatal overdose among heroin users entering treatment.
    Neale J; Robertson M
    Addiction; 2005 Feb; 100(2):168-75. PubMed ID: 15679746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Teesson M; Ross J; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
    Drug Alcohol Depend; 2006 Jun; 83(2):174-80. PubMed ID: 16343809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between cocaine use and short-term outcomes for the treatment of heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Williamson A; Darke S; Ross J; Teesson M
    Drug Alcohol Rev; 2006 Mar; 25(2):141-8. PubMed ID: 16627303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of major depression and drug-related problems amongst heroin users across 36 months.
    Darke S; Mills K; Teesson M; Ross J; Williamson A; Havard A
    Psychiatry Res; 2009 Mar; 166(1):7-14. PubMed ID: 19215987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of treatment on 3 years' outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Teesson M; Mills K; Ross J; Darke S; Williamson A; Havard A
    Addiction; 2008 Jan; 103(1):80-8. PubMed ID: 17995994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Young people with heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Mills KL; Teesson M; Darke S; Ross J; Lynskey M
    J Subst Abuse Treat; 2004 Jul; 27(1):67-73. PubMed ID: 15223096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of borderline personality disorder on 12-month outcomes for the treatment of heroin dependence.
    Darke S; Ross J; Williamson A; Teesson M
    Addiction; 2005 Aug; 100(8):1121-30. PubMed ID: 16042642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Andalusian trial on heroin-assisted treatment: a 2 year follow-up.
    Oviedo-Joekes E; March JC; Romero M; Perea-Milla E
    Drug Alcohol Rev; 2010 Jan; 29(1):75-80. PubMed ID: 20078686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reductions in heroin use are not associated with increases in other drug use: 2-year findings from the Australian Treatment Outcome Study.
    Darke S; Williamson A; Ross J; Teesson M
    Drug Alcohol Depend; 2006 Sep; 84(2):201-5. PubMed ID: 16580792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS).
    Ross J; Teesson M; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
    Drug Alcohol Rev; 2005 Sep; 24(5):411-8. PubMed ID: 16298835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-injecting routes of administration among entrants to three treatment modalities for heroin dependence.
    Darke S; Hetherington K; Ross J; Lynskey M; Teesson M
    Drug Alcohol Rev; 2004 Jun; 23(2):177-83. PubMed ID: 15370024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEdeTTE, a longitudinal study on effectiveness of treatments for heroin addiction in Italy: study protocol and characteristics of study population.
    Bargagli AM; Faggiano F; Amato L; Salamina G; Davoli M; Mathis F; Cuomo L; Schifano P; Burroni P; Perucci CA;
    Subst Use Misuse; 2006; 41(14):1861-79. PubMed ID: 17162594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes and predictors of change in the physical health status of heroin users over 24 months.
    Williamson A; Darke S; Ross J; Teesson M
    Addiction; 2009 Mar; 104(3):465-70. PubMed ID: 19207357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of sustained heroin abstinence amongst long-term, dependent heroin users: 36 months findings from the Australian Treatment Outcome Study (ATOS).
    Darke S; Ross J; Mills KL; Williamson A; Havard A; Teesson M
    Addict Behav; 2007 Sep; 32(9):1897-906. PubMed ID: 17289282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When is a little knowledge dangerous? Circumstances of recent heroin overdose and links to knowledge of overdose risk factors.
    Dietze P; Jolley D; Fry CL; Bammer G; Moore D
    Drug Alcohol Depend; 2006 Oct; 84(3):223-30. PubMed ID: 16542798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a sustained heroin shortage in three Australian States.
    Degenhardt L; Day C; Dietze P; Pointer S; Conroy E; Collins L; Hall W
    Addiction; 2005 Jul; 100(7):908-20. PubMed ID: 15954999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.